Jan I, Chen K, Sayan M, et al. - As studies evaluating environmental contamination with SARS-CoV-2 in clinics that do not routinely treat patients with COVID-19 are lacking and greater morbidity and mortality may occur among patients who have cancer and become infected with SARS-CoV-2 compared with the general public, researchers sought to assess the presence or absence of SARS-CoV-2 in a radiation oncology clinic in order to provide relevant information for health care practitioners, patients, and their families, who must weigh the benefit of cancer treatment vs the risk of infection with SARS-CoV-2. They tested a total of 128 environmental samples in the radiation oncology department, and identified 0 as positive for SARS-CoV-2. This suggest no detectable SARS-CoV-2 RNA in systematic testing of environmental surfaces in the radiation oncology clinic. Because of fears about COVID-19, many of the patients with cancer at their clinic have deferred or canceled their scheduled follow-up visits, and there was a substantial decreases in patient volume was observed in many radiation oncology clinics. Although rescheduling follow-up visits or converting selected follow-up visits and consultations to telemedicine is good practice during the pandemic, delaying or declining important cancer therapies by some patients or clinicians can substantially affect quality of life and cancer outcomes. Based on observations, they emphasize not to delay appropriate patient care because of the pandemic. They indicate that surface contamination with SARS-CoV-2 may adequately be limited with following strict prevention protocols and routine cleaning and disinfecting.